Subscribe to the Magazine View this as website Why Big Pharma sees the abortion drug legal fight as a grave business risk One year after the nation learned of the Supreme Court's intent to peel back federal protections for abortions via a leaked draft opinion, a new legal fight over the approval of a common abortion drug has ignited condemnation from nearly every corner of the pharmaceutical industry. Read the full story here. Latest News in US Healthcare Vermont becomes first state to allow non...